Skip to content
NYSE · CHEMICALS & ALLIED PRODUCTS · LARGE CAP

FMC Corp. FMC

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$3.5B
▼ 18.3% YoY
$-2.2B
▼ 756.4% YoY
$-102.5M
▼ 115.3% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

FMC Corporation develops, markets and sells all three major classes of crop protection chemicals (insecticides, herbicides and fungicides), as well as biologicals, crop nutrition and seed treatment products, which it groups as plant health. The company employs approximately 5,500 people, split across its major geographical regions with 21 percent in North America, 13 percent in Latin America, 27 percent in Europe, Middle East and Africa, and 39 percent in Asia as of December 31, 2025. As of December 31, 2025, the company owned approximately 162 active granted U.S. patents and 2,133 active granted foreign patents, and had approximately 1,648 patent applications pending globally. It operates in a single distinct business segment.

Written from the business description in FMC CORPORATION's annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth

USD 3.5B
Revenue, FY2025 · full 19-year series below
Revenue $B Net income $B
FY2025 · Revenue 3.5 · Net income -2.2
2.5B5.0B-1.0B-2.0B
2007201020132016201920222025
Compound annual growth
−15.8%
−5.7%
+3.4%
+0.7%
−5.7%
+0.2%
+10.7%
+14.1%
−6.7%
+2.8%
+12.9%
+4.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −5.7% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−65 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -47.0% · Net -64.5%
10%20%-20%-40%-60%
200720162025
ROE
FY2025 · ROE -68.3%
10%20%30%-20%-40%-60%
200720162025
Three returns, three denominators.

Each USD of equity lost 68 cents this year.

Cash & shareholders

USD 291.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -102.5
300M600M-200M-400M
200720162025
Net buybacks $M Dividends $M
FY2025 · Dividends 291.3 · Net buybacks -0.2
250.0M500.0MDividendsNet buybacks
2007201020132016201920222025

USD 291.3M in dividends went back to shareholders in a year without profit.

Total assetsUSD 9.7B
EquityUSD 2.1B
CashUSD 584.5M
Gross debtUSD 3.4B
Net debtUSD 2.8B
Current ratio1.32×

Net debt stands at 134% of equity.

The 19-year record

19 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
FMC, 19-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B3.54.24.55.85.04.64.64.32.52.52.53.33.13.43.03.12.83.12.6
Operating income $B−1.60.50.61.11.00.90.80.70.20.3−0.10.40.50.60.60.40.30.50.2
EBITDA $B−1.50.70.71.31.21.11.00.90.30.4−0.10.50.60.80.70.50.50.60.4
Income tax $B0.3−0.2−1.10.10.10.20.10.10.20.10.00.10.10.10.10.10.10.10.0
Net income $B−2.20.31.30.70.70.60.50.50.50.20.50.30.30.40.40.20.20.30.1
Free cash flow $B−0.10.7−0.40.50.80.70.50.30.20.3−0.50.10.10.20.30.30.20.20.2
EPS, diluted $−17.882.7210.535.815.734.233.623.693.991.563.662.292.163.002.551.183.124.021.71
Dividend / sh $1.822.322.322.171.961.801.640.900.660.660.660.600.540.410.300.250.500.480.41
Payout %−13852236334144181742182525111121161122
ROE %−68.37.733.922.724.320.116.917.323.110.928.820.219.630.630.915.623.130.111.8

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 89 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. Two checks were skipped: the share count is not tagged before 2009. Two checks were skipped: the balance sheet is not tagged before 2008.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityChemicals & Allied Products
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image